Amedeo's Top 20

Amedeo Smart

Independent Medical Education

05 December 2022

Multidisciplinary Journal Club

  1. Jackson S, Kabir Z, Comiskey C.
    Impact of universal tuberculosis vaccination cessation on the epidemiology of paediatric tuberculosis cases in Ireland from 2011 to 2021.
    Lancet 2022;400 :S53.

  1. Ahmad E, Lim S, Lamptey R, Webb DR, et al.
    Type 2 diabetes.
    Lancet 2022.

  2. Murillo Perez CF, Fisher H, Hiu S, Kareithi D, et al.
    Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
    Gastroenterology 2022.

  3. Cardoso F.
    The brain-fat connection.
    Science 2022;378:485.

  4. Ossenkoppele R, Pichet Binette A, Groot C, Smith R, et al.
    Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline.
    Nat Med 2022;28:2381-2387.

  1. Okuda DT, Kantarci O, Lebrun-Frenay C, Sormani MP, et al.
    Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome.
    Ann Neurol 2022.

  2. Islami F, Ward EM, Sung H, Cronin KA, et al.
    Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics.
    J Natl Cancer Inst 2021;113:1648-1669.

  3. Ghobadi A, Slade M, Kantarjian H, Alvarenga J, et al.
    The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis.
    Blood 2022;140:2101-2112.

  4. Escalard S, Chalumeau V, Escalard C, Redjem H, et al.
    Early Brain Imaging Shows Increased Severity of Acute Ischemic Strokes With Large Vessel Occlusion in COVID-19 Patients.
    Stroke 2020.

  5. Degasperi E, Anolli MP, Uceda Renteria SC, Sambarino D, et al.
    Bulevirtide monotherapy for 48 Weeks in hdv patients with compensated cirrhosis and clinically significant portal hypertension.
    J Hepatol 2022.

  1. Spelman T, Ozakbas S, Alroughani R, Terzi M, et al.
    Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
    Mult Scler 2022.

  2. Oeverhaus M, Koenen J, Bechrakis N, Stohr M, et al.
    Radioiodine ablation of thyroid remnants in patients with Graves' orbitopathy.
    J Nucl Med 2022.

  3. Trullas JC, Morales-Rull JL, Casado J, Carrera-Izquierdo M, et al.
    Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial.
    Eur Heart J 2022.

  4. Louvet A, Bourcier V, Archambeaud I, d'Alteroche L, et al.
    Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort.
    J Hepatol 2022.

  5. Ferreira-Atuesta C, de Tisi J, McEvoy AW, Miserocchi A, et al.
    Predictive models for starting antiseizure medication withdrawal following epilepsy surgery in adults.
    Brain 2022.

  1. Rumgay H, Arnold M, Ferlay J, Lesi O, et al.
    Global burden of primary liver cancer in 2020 and predictions to 2040.
    J Hepatol 2022;77:1598-1606.

  2. Davidson LJ, Cleveland JC, Welt FG, Anwaruddin S, et al.
    A Practical Approach to Left Main Coronary Artery Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol 2022;80:2119-2134.

  3. Cui W, Francis PA, Loi S, Hickey M, et al.
    Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation.
    J Natl Cancer Inst 2021;113:1770-1778.

  4. Rugo HS, Loi S, Adams S, Schmid P, et al.
    PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer.
    J Natl Cancer Inst 2021;113:1733-1743.

  5. Wong ECL, Dulai PS, Marshall JK, Jairath V, et al.
    Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn's Disease.
    Inflamm Bowel Dis 2022.


more..

Privacy Policy